David Nadell

Managing Director, Strategic Value Advisory at Kroll

Speaker

David has nearly 20 years of experience helping life sciences companies on a range of valuation issues. David has developed and reviewed financial projections, determined fair market value for products and services subject to anti-kickback and other health care regulatory compliance issues, valued licensing agreements, benchmarked potential licensing terms, equity and employee stock options valuations, and valued contingent consideration.